文献速递腹部泌尿生殖CT

肝细胞癌监测中盆腔CT的应用价值:一项回顾性多中心研究

Utility of pelvic CT in patients undergoing surveillance for hepatocellular carcinoma: A retrospective multi-institutional study.
PubMed 文献 · Abdom Radiol (NY) · 2024-06-04

本研究回顾性分析两中心259例肝细胞癌高危患者共327次腹盆腔CT监测检查,报告622个盆腔发现(平均2.2个/次),其中52个(8.3%)伴有可操作建议,仅8项建议最终产生临床结局,4例为尿路感染治疗。盆腔CT发现仅在1.3%的检查中带来临床获益,作者认为基于CT的肝细胞癌监测可省略盆腔成像。

要点

  • 肝细胞癌监测CT中盆腔发现虽常见(平均2.2个/次),但仅1.3%的检查带来临床获益。
  • 622个盆腔发现中仅52个(8.3%)伴有可操作建议,其中仅8项建议最终产生临床结局。
  • 作者认为基于CT的肝细胞癌监测可省略盆腔成像,不损失有价值信息。

核心结论

  • 盆腔CT发现仅在1.3%的检查中为患者带来临床获益,作者认为基于CT的肝细胞癌监测应省略盆腔成像。

研究设计与样本

  • 两中心回顾性研究,经机构审查委员会批准并豁免知情同意,纳入259例肝细胞癌高危成人,回顾2010年1月1日至2023年2月28日期间共327次腹盆腔CT监测检查。

关键影像表现/征象

  • 共报告622个盆腔发现(平均2.2个/次),包括膀胱131个、消化道120个、血管133个、妇科51个、前列腺37个、淋巴结33个、腹股沟27个、腹膜44个、骨骼46个。
  • 622个发现中52个(8.3%)伴有可操作建议。
  • 52项可操作建议中24项被实施:5项补充影像、10项额外实验室检查、9项非影像建议。
  • 仅8项被实施建议最终产生临床结局,包括4例尿路感染治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine the frequency, characteristics and clinical significance of incidental pelvic findings reported on abdominopelvic CT performed for hepatocellular carcinoma (HCC) surveillance in at-risk patients.

MATERIAL AND METHODS: This two-center retrospective study received institutional review board approval with a waiver of informed consent. The radiologic reports of the CT exams performed 1/1/2010-2/28/2023 for HCC surveillance were reviewed. Exams were obtained with intravenous contrast material and included hepatic arterial and portal venous phases of the abdomen; images of the pelvis were acquired during the portal venous phase. Reported imaging findings and imaging-related recommendations either by the radiologists or the corresponding caregiver, if present, were retrospectively tabulated. The patient's medical records were reviewed to determine if there were any recommendations that were considered clinically important and culminated in any further interventions or treatments.

RESULTS: 259 adults (1st center: mean age, 60 ± 11 years, 49% male and 2nd center: 56.26 ± 6.2 years, 48% male) at risk for HCC underwent 327 abdominopelvic CT exams for HCC surveillance at two centers. A total of 622 pelvic findings (mean, 2.2/ exam) were reported, including 131 bladder, 120 alimentary tract, 133 vascular, 51 gynecologic, 37 prostate, 33 lymph node, 27 inguinal, 44 peritoneal, and 46 skeletal. 52 of 622 reported findings (8.3%) were associated with actionable recommendations. 24 of the 52 actionable recommendations/clinical suggestions were implemented as follows: five complimentary imaging, ten additional laboratory tests, and nine non-imaging recommendations. Of note, only eight applied recommendations culminated in a clinical outcome, which included four urinary tract infection treatments.

CONCLUSION: Pelvic CT findings were associated with a clinical benefit to the patient in 1.3% of exams. These results suggest that pelvic imaging should be omitted from CT-based HCC surveillance.

CLINICAL RELEVANCE: Without compromising valuable information, patients undergoing HCC surveillance-CT may not require additional pelvic coverage.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Shahbazian H, Raja K, Sirlin C, et al. Utility of pelvic CT in patients undergoing surveillance for hepatocellular carcinoma: A retrospective multi-institutional study. Abdom Radiol (NY). 2024. PMID: 38831071. doi:10.1007/s00261-024-04362-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。